NDRA
ENDRA Life Sciences Inc.
Price Chart
Latest Quote
$5.31
+0.13 (+2.51%)
Current Price
| Previous Close | $5.18 |
| Open | $5.15 |
| Day High | $5.31 |
| Day Low | $4.80 |
| Volume | 12,140 |
Stock Information
| Shares Outstanding | 1.85M |
| Total Debt | $461K |
| Cash Equivalents | $356K |
| Net Income | $-7.30M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Market Cap | $9.82M |
| EPS (TTM) | $-8.16 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $6.85M |
| Income | $-7.30M |
| Book/sh | $1.52 |
| Cash/sh | $0.19 |
| Employees | 9 |
Financial Ratios
| Quick Ratio | 0.43 |
| Current Ratio | 0.64 |
| Debt/Eq | 25.81 |
Returns & Margins
| ROA | -122.33% |
| ROE | -412.60% |
Ownership
| Insider Ownership | 9.76% |
| Institutional Ownership | 11.13% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -1.75 |
| P/B | 3.50 |
Analyst Data
| Recommendation | none |
| Target Price | $25.00 |
Technical Indicators
| SMA20 | $4.88 |
| SMA50 | $5.09 |
| SMA200 | $4.91 |
| RSI | 54.15 |
| ATR | 0.4658 |
| Shares Float | 1.20M |
| Short Float | 1.65% |
| Short Ratio | 1.18 |
| Volatility | -0.04 |
| Rel Volume | 0.72 |
Performance History
| Week | +9.48% |
| Month | -0.75% |
| Quarter | +52.59% |
| 6 Months | +4.94% |
| YTD | +23.78% |
| Year | +66.46% |
| 3 Years | -99.79% |
| 5 Years | -99.99% |
| 10 Years | -100.00% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $5.31 | 12,100 |
| 2026-06-22 | $5.18 | 14,100 |
| 2026-06-18 | $4.76 | 15,400 |
| 2026-06-17 | $5.01 | 14,200 |
| 2026-06-16 | $4.69 | 24,000 |
| 2026-06-15 | $4.85 | 28,700 |
| 2026-06-12 | $4.56 | 12,700 |
| 2026-06-11 | $4.44 | 15,900 |
| 2026-06-10 | $4.19 | 9,300 |
| 2026-06-09 | $4.42 | 18,300 |
| 2026-06-08 | $4.27 | 10,800 |
| 2026-06-05 | $4.23 | 7,400 |
| 2026-06-04 | $4.77 | 7,000 |
| 2026-06-03 | $4.73 | 12,800 |
| 2026-06-02 | $5.04 | 33,400 |
| 2026-06-01 | $5.60 | 8,200 |
| 2026-05-29 | $5.50 | 9,800 |
| 2026-05-28 | $5.52 | 36,600 |
| 2026-05-27 | $5.36 | 30,000 |
| 2026-05-26 | $5.20 | 15,000 |
About ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source such as radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion analysis. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
đ° Latest News
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $0 | $0 |
| Operating Revenue | $0 | $0 | $0 | $0 |
| Expenses | ||||
| Total Expenses | $5,763,101 | $10,817,147 | $10,520,735 | $13,157,559 |
| Other Income Expense | $-1,264,309 | $-690,800 | $460,485 | $-21,533 |
| Other Non Operating Income Expenses | $76,345 | $108,484 | $460,485 | $-21,533 |
| Operating Expense | $5,763,101 | $10,817,147 | $10,520,735 | $13,157,559 |
| Selling And Marketing Expense | $189,470 | $571,040 | $820,554 | $1,429,150 |
| General And Administrative Expense | $3,723,635 | $7,055,814 | $4,696,486 | $5,174,215 |
| Net Non Operating Interest Income Expense | - | $-7,323,685 | - | - |
| Total Other Finance Cost | - | $7,323,685 | - | - |
| Interest Expense | - | - | - | - |
| Interest Expense Non Operating | - | - | - | - |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-7,027,410 | $-11,507,947 | $-10,060,250 | $-13,179,092 |
| Normalized Income | $-5,686,756 | $-10,708,663 | $-10,060,250 | $-13,179,092 |
| Net Income From Continuing And Discontinued Operation | $-7,027,410 | $-11,507,947 | $-10,060,250 | $-13,179,092 |
| Total Operating Income As Reported | $-5,763,101 | $-10,817,147 | $-10,520,735 | $-13,157,559 |
| Net Income Common Stockholders | $-7,027,410 | $-11,507,947 | $-10,060,250 | $-13,179,092 |
| Net Income | $-7,027,410 | $-11,507,947 | $-10,060,250 | $-13,179,092 |
| Net Income Including Noncontrolling Interests | $-7,027,410 | $-11,507,947 | $-10,060,250 | $-13,179,092 |
| Net Income Continuous Operations | $-7,027,410 | $-11,507,947 | $-10,060,250 | $-13,179,092 |
| Pretax Income | $-7,027,410 | $-11,507,947 | $-10,060,250 | $-13,179,092 |
| Operating Income | $-5,763,101 | $-10,817,147 | $-10,520,735 | $-13,157,559 |
| Net Interest Income | - | $-7,323,685 | - | - |
| Special Income Charges | - | - | - | $0 |
| Gross Profit | - | - | - | - |
| Per Share | ||||
| Diluted EPS | $-8.93 | $-56.94 | $-2766.85 | $-7980.00 |
| Basic EPS | $-8.93 | $-56.94 | $-2766.85 | $-7980.00 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-4,265,153 | $-9,811,691 | $-10,245,284 | $-12,923,301 |
| Total Unusual Items | $-1,340,654 | $-799,284 | - | $0 |
| Total Unusual Items Excluding Goodwill | $-1,340,654 | $-799,284 | - | $0 |
| Reconciled Depreciation | $157,294 | $206,172 | $275,451 | $234,258 |
| EBITDA (Bullshit earnings) | $-5,605,807 | $-10,610,975 | $-10,245,284 | $-12,923,301 |
| EBIT | $-5,763,101 | $-10,817,147 | $-10,520,735 | $-13,157,559 |
| Diluted Average Shares | $787,020 | $202,106 | $3,636 | $1,652 |
| Basic Average Shares | $787,020 | $202,106 | $3,636 | $1,652 |
| Diluted NI Availto Com Stockholders | $-7,027,410 | $-11,507,947 | $-10,060,250 | $-13,179,092 |
| Tax Provision | $0 | $0 | $0 | $0 |
| Gain On Sale Of Security | $-1,340,654 | $-799,284 | - | - |
| Research And Development | $1,849,996 | $3,190,293 | $5,003,695 | $6,554,194 |
| Selling General And Administration | $3,913,105 | $7,626,854 | $5,517,040 | $6,603,365 |
| Other Gand A | $3,723,635 | $7,055,814 | $4,696,486 | $5,174,215 |
| Otherunder Preferred Stock Dividend | - | - | - | $0 |
| Other Special Charges | - | - | - | - |
Fetched: 2026-06-23
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $250,160 | $2,560,366 | $5,658,989 | $7,204,504 |
| Total Assets | $3,853,797 | $4,452,362 | $6,754,146 | $9,274,147 |
| Total Non Current Assets | $2,885,828 | $1,018,697 | $3,721,334 | $3,894,750 |
| Other Non Current Assets | $5,986 | $5,986 | $2,628,851 | $2,650,703 |
| Non Current Prepaid Assets | $365,417 | $365,417 | $626,610 | $502,576 |
| Goodwill And Other Intangible Assets | $2,009,960 | $0 | - | - |
| Other Intangible Assets | $2,009,960 | - | - | - |
| Current Assets | $967,969 | $3,433,665 | $3,032,812 | $5,379,397 |
| Prepaid Assets | $205,604 | $204,185 | $198,905 | $490,299 |
| Cash Cash Equivalents And Short Term Investments | $762,365 | $3,229,480 | $2,833,907 | $4,889,098 |
| Cash And Cash Equivalents | $762,365 | $3,229,480 | $2,833,907 | $4,889,098 |
| Cash Financial | $762,365 | $3,229,480 | $2,833,907 | $4,889,098 |
| Inventory | - | - | - | $2,644,717 |
| Debt | ||||
| Total Debt | $492,352 | $584,419 | $394,403 | $546,631 |
| Long Term Debt And Capital Lease Obligation | $362,974 | $487,482 | $192,062 | $365,919 |
| Current Debt And Capital Lease Obligation | $129,378 | $96,937 | $202,341 | $180,712 |
| Current Debt | - | - | $28,484 | $28,484 |
| Other Current Borrowings | - | - | $28,484 | $28,484 |
| Long Term Debt | - | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $1,593,677 | $1,891,996 | $1,095,157 | $2,069,643 |
| Total Non Current Liabilities Net Minority Interest | $842,721 | $1,286,766 | $192,062 | $365,919 |
| Derivative Product Liabilities | $479,747 | $799,284 | $0 | - |
| Current Liabilities | $750,956 | $605,230 | $903,095 | $1,703,724 |
| Payables And Accrued Expenses | $615,828 | $502,543 | $659,486 | $833,524 |
| Payables | $382,970 | $269,683 | $360,401 | $613,961 |
| Accounts Payable | $382,970 | $269,683 | $360,401 | $613,961 |
| Equity | ||||
| Common Stock Equity | $2,260,120 | $2,560,366 | $5,658,988 | $7,204,503 |
| Total Equity Gross Minority Interest | $2,260,120 | $2,560,366 | $5,658,989 | $7,204,504 |
| Stockholders Equity | $2,260,120 | $2,560,366 | $5,658,989 | $7,204,504 |
| Retained Earnings | $-110,465,509 | $-103,438,099 | $-91,930,152 | $-81,869,902 |
| Preferred Stock Equity | - | - | $1 | $1 |
| Other Equity Interest | - | - | $5,233 | $6,073 |
| Other | ||||
| Ordinary Shares Number | $1,176,477 | $536,908 | $5,937 | $1,810 |
| Share Issued | $1,176,477 | $536,908 | $5,937 | $1,810 |
| Tangible Book Value | $250,160 | $2,560,366 | $5,658,988 | $7,204,503 |
| Invested Capital | $2,260,120 | $2,560,366 | $5,687,472 | $7,232,987 |
| Working Capital | $217,013 | $2,828,435 | $2,129,717 | $3,675,673 |
| Capital Lease Obligations | $492,352 | $584,419 | $365,919 | $518,147 |
| Total Capitalization | $2,260,120 | $2,560,366 | $5,658,989 | $7,204,504 |
| Additional Paid In Capital | $112,725,513 | $105,998,412 | $97,583,906 | $89,068,015 |
| Capital Stock | $116 | $53 | $2 | $318 |
| Common Stock | $116 | $53 | $1 | $317 |
| Preferred Stock | $0 | $0 | $1 | $1 |
| Long Term Capital Lease Obligation | $362,974 | $487,482 | $192,062 | $365,919 |
| Current Capital Lease Obligation | $129,378 | $96,937 | $173,857 | $152,228 |
| Pensionand Other Post Retirement Benefit Plans Current | $5,750 | $5,750 | $41,268 | $689,488 |
| Current Accrued Expenses | $232,858 | $232,860 | $299,085 | $219,563 |
| Net PPE | $504,465 | $647,294 | $465,873 | $741,471 |
| Accumulated Depreciation | $-679,870 | $-635,824 | $-600,399 | $-643,682 |
| Gross PPE | $1,184,335 | $1,283,118 | $1,066,272 | $1,385,153 |
| Construction In Progress | $125,151 | $125,151 | $125,151 | $140,617 |
| Other Properties | $461,949 | $578,013 | $354,091 | $505,816 |
| Properties | $597,235 | $579,954 | $587,030 | $738,720 |
| Preferred Shares Number | - | - | - | $141 |
| Raw Materials | - | - | - | - |
Fetched: 2026-06-23
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-8,199,838 | $-7,416,547 | $-9,582,659 | $-12,971,948 |
| Operating Activities | ||||
| Operating Cash Flow | $-5,182,558 | $-7,400,547 | $-9,548,775 | $-12,769,371 |
| Cash Flow From Continuing Operating Activities | $-5,182,558 | $-7,400,546 | $-9,548,775 | $-12,769,371 |
| Operating Gains Losses | $345,493 | $799,284 | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-3,017,280 | $-16,000 | $-33,884 | $-202,577 |
| Investing Cash Flow | $-3,017,280 | $-12,796 | $-24,721 | $-202,577 |
| Cash Flow From Continuing Investing Activities | $-3,017,280 | $-12,796 | $-24,721 | $-202,577 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $5,732,723 | $6,516,834 | $6,483,393 | $8,399,512 |
| Financing Cash Flow | $5,732,723 | $7,808,917 | $7,518,305 | $8,399,512 |
| Cash Flow From Continuing Financing Activities | $5,732,723 | $7,808,917 | $7,518,305 | $8,399,512 |
| Net Common Stock Issuance | $5,732,723 | $6,516,834 | $6,483,393 | $8,399,512 |
| Common Stock Issuance | $5,732,723 | $6,516,834 | $6,483,393 | $8,399,512 |
| Net Other Financing Charges | - | $1 | - | - |
| Other | ||||
| Repayment Of Debt | $0 | $-28,484 | - | - |
| Interest Paid Supplemental Data | $55,848 | $31,910 | $44,985 | $59,113 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $0 |
| End Cash Position | $762,365 | $3,229,480 | $2,833,907 | $4,889,098 |
| Beginning Cash Position | $3,229,480 | $2,833,907 | $4,889,098 | $9,461,534 |
| Changes In Cash | $-2,467,115 | $395,573 | $-2,055,191 | $-4,572,436 |
| Proceeds From Stock Option Exercised | $0 | $1,320,567 | $1,034,912 | $0 |
| Net Issuance Payments Of Debt | $0 | $-28,484 | - | - |
| Net Long Term Debt Issuance | $0 | $-28,484 | - | - |
| Long Term Debt Payments | $0 | $-28,484 | - | - |
| Net Intangibles Purchase And Sale | $-3,000,000 | $0 | - | - |
| Purchase Of Intangibles | $-3,000,000 | $0 | - | - |
| Net PPE Purchase And Sale | $-17,280 | $-12,796 | $-24,721 | $-202,577 |
| Sale Of PPE | $0 | $3,204 | $9,163 | $0 |
| Purchase Of PPE | $-17,280 | $-16,000 | $-33,884 | $-202,577 |
| Change In Working Capital | $22,616 | $134,079 | $-923,319 | $-1,025,766 |
| Change In Other Current Liabilities | $-89,252 | $-158,698 | $-152,228 | $-132,330 |
| Change In Payables And Accrued Expense | $113,287 | $-198,867 | $-822,258 | $111,575 |
| Change In Prepaid Assets | $-1,419 | $255,913 | $167,360 | $355,128 |
| Change In Inventory | $0 | $235,731 | $-116,193 | $-1,360,139 |
| Other Non Cash Items | $-5,121 | $-1 | - | - |
| Stock Based Compensation | $329,409 | $571,924 | $996,430 | $1,199,838 |
| Unrealized Gain Loss On Investment Securities | $995,161 | $0 | - | - |
| Provisionand Write Offof Assets | $0 | $2,387,134 | $138,045 | $0 |
| Asset Impairment Charge | $0 | $8,808 | $24,868 | $1,391 |
| Depreciation Amortization Depletion | $157,294 | $206,172 | $275,451 | $234,258 |
| Depreciation And Amortization | $157,294 | $206,172 | $275,451 | $234,258 |
| Depreciation | $157,294 | $206,172 | $275,451 | $234,258 |
| Gain Loss On Investment Securities | $345,493 | $799,284 | - | - |
| Net Income From Continuing Operations | $-7,027,410 | $-11,507,947 | $-10,060,250 | $-13,179,092 |
| Net Short Term Debt Issuance | - | $-28,484 | - | - |
| Short Term Debt Payments | - | $-28,484 | - | - |
| Issuance Of Debt | - | - | - | - |
| Long Term Debt Issuance | - | - | - | - |
| Change In Other Current Assets | - | - | - | - |
Fetched: 2026-06-23